Scale Management’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$752K Buy
+178,259
New +$799K 0.21% 2
2016
Q3
$5.92M Hold
264,881
13.02% 3
2016
Q2
$4.89M Sell
264,881
-33,612
-11% -$894K 11.57% 3
2016
Q1
$7.83M Hold
298,493
15.62% 3
2015
Q4
$10.8M Hold
298,493
16.59% 2
2015
Q3
$9.89M Sell
298,493
-62
-0% -$3.49K 12.3% 4
2015
Q2
$20.6M Sell
298,555
-5,344
-2% -$369K 13.45% 4
2015
Q1
$22.8M Hold
303,899
11.41% 3
2014
Q4
$25.3M Buy
+303,899
New +$24.7M 14.42% 4

Other funds holding ALIM

Scale Management's ALIM Position: Q4 2020 in Review

Scale Management opened a new position in Alimera Sciences (ALIM) in Q4 2020: 178,259 shares worth $752K. The stake represents 0.21% of the portfolio and ranks #2 among its holdings. This is a return to the name: Scale Management previously reported a position in ALIM as recently as Q3 2016.

Scale Management first reported a position in ALIM in Q4 2014 and has held it in 9 quarters since. The position peaked at $25.3M in Q4 2014. 19 funds tracked by Wall St. Rank hold ALIM as of Q4 2020.

  • Scale Management held 178,259 shares of Alimera Sciences worth $752K as of Q4 2020.
  • Alimera Sciences was a new Scale Management position in Q4 2020.
  • Alimera Sciences made up 0.21% of Scale Management's portfolio in Q4 2020, its #2 holding.
  • Scale Management first reported a position in Alimera Sciences in Q4 2014 and has held it in 9 quarters since.
  • Scale Management's Alimera Sciences position peaked at $25.3M in Q4 2014.
  • 19 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2020.

Based on Scale Management's 13F filing for Q4 2020, filed 12 Feb 2021.